The Australian National University (ANU), in collaboration with The Florey Institute of Neuroscience and Mental Health, have developed a new type of hydrogel that could radically transform how we treat Parkinson’s disease.
The gel also offers hope for patients who have suffered from other neurological conditions such as strokes.
The new material is made from natural amino acids—the building blocks of proteins—and acts as a gateway to facilitate the safe transfer of stem cells into the brain and restore damaged tissue by releasing a growth-enabling protein called GDNF.
Medications of Parkinson’s Disease or Once Upon A Pill:
Harnessing Probiotics to Deliver Parkinson’s Disease Treatment
